±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 3172  |  »Ø¸´: 7

lb1527

½ð³æ (СÓÐÃûÆø)

[ÇóÖú] ¸å¼þ±»¾Ü£¬±à¼­¸øÁËÁíÍâÍÆ¼öÔÓÖ¾£¬²»ÏëͶ£¬ÎÒÓ¦¸ÃÔõô¸øÖ®Ç°µÄ±à¼­»Ø¸å¼þÄØ~¼±Çó~ ÒÑÓÐ6È˲ÎÓë

¸å¼þ±»¾Ü£¬±à¼­¸øÁËÁíÍâµÄÒ»¸öÍÆ¼öÔÓÖ¾£¬¿ÉÊÇÄǸöÔÓÖ¾·ÇSCI£¬ÎÒÓ¦¸ÃÔõô¸øÖ®Ç°µÄ±à¼­»Ø¸å¼þÄØ~¼±Çó~

Thank you very much for the opportunity to consider your manuscript "Ameliorative effects of a promising AChE inhibitor nootkatone on impaired learning behavior in A¦Â1-42-injecet mouse" for publication in Drugs & Aging.

We regret that we are unable to consider your paper for publication in this journal, as Drugs & Aging does not generally publish preclinical animal studies of this kind.  

However, the topic is of interest for our sister journal, Drugs in R & D, and we would like to recommend that this article be considered for publication in this journal.

Drugs in R & D is a Medline-indexed, peer-reviewed journal and accepts research on drugs in every stage of development. The journal is an 'open-access' journal, i.e. if accepted for publication, your paper will be freely available to readers all over the world from the journal home page on SpringerLink. As an open access journal, Drugs in R & D does not have paying subscribers and therefore manuscript processing and publishing charges are normally recouped via the Article Processing Charge (APC). However, as this is a recommended transfer from Drugs & Aging, the Editor would be prepared to waive the usual charge if you choose to transfer your submission.

As with all Adis manuscripts, your manuscript will be independently peer reviewed and edited by experts. Further information about this journal can be found at www.Springer.com/journal/40268.

We look forward to hearing from you shortly.

With kind regards,
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

Ê·èÉôÁ

Ìú³æ (³õÈëÎÄ̳)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
²»Óûظ´¾ÍÐÐÁË£¬È»ºóÔÙÕÒÄãÏë·¢±íµÄÆÚ¿¯¾ÍÐÐÁË¡£¡£¡£
ŬÁ¦Á˾ͺᣡ£¡£¡£
2Â¥2014-03-21 13:36:44
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

makunjida

ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
²»ÐèÒª»Ø¸´µÄ±à¼­Ö»ÊÇÌ×Ä£°å»Ø¸´µÄ

[ ·¢×ÔÊÖ»ú°æ http://muchong.com/3g ]
3Â¥2014-03-21 14:41:35
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

lb1527

½ð³æ (СÓÐÃûÆø)

ÒýÓûØÌû:
2Â¥: Originally posted by Ê·èÉôÁ at 2014-03-21 13:36:44
²»Óûظ´¾ÍÐÐÁË£¬È»ºóÔÙÕÒÄãÏë·¢±íµÄÆÚ¿¯¾ÍÐÐÁË¡£¡£¡£

¿ÉÊÇÏÖÔÚÎÒÎÄÕµÄ״̬ÊÇSubmission Transferred ²»ÊÇreject¡£¿ÉÊÇתͶÂð
4Â¥2014-03-21 14:51:05
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

huicun

ľ³æ (ÖøÃûдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
תͶ°É£¬±à¼­ÒѾ­¾ÜÁË£¬Óʼþ¾ÍÊÇÖ¤Ã÷¡£
µÇ¸ßÍûÔ¶£¡
5Â¥2014-03-21 16:14:43
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ws861227

Ìú³æ (ÖøÃûдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ÕÒ±ðµÄÆÚ¿¯°É£¬²»Óûظ´µÄ
6Â¥2014-03-21 17:31:46
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

gaojunhn

ľ³æ (ÕýʽдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
lb1527: ½ð±Ò+3, ¡ïÓаïÖú 2014-03-22 12:55:31
»ØÐÅ˵Äã²»ÏëͶ°¡  ÕâÖÖÇé¿ö±ØÐëÒª»Ø°¡  Â¥É϶¼ÊÇû¿´ÇåÓʼþ¾ÍÂÒ´ð    È˼ÒÃ÷Ã÷˵ÁË We look forward to hearing from you shortly.
¶øÇÒÄãµÄ¸å¼þ״̬Ҳ²»ÊǾܸ堠ÕâÖÖÇé¿öͶÆäËûÔÓÖ¾²»¾ÍÊÇÒ»¸å¶àͶÂð£¿
Ìṩscifinder ¡¢reaxys ¡¢È«¿â¼°thomson pharma
7Â¥2014-03-21 19:08:32
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

wangjun890

ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
²»ÒªÄãµÄ¸å£¬ºÎ±Ø»¹ÒªÀíËû¡£
ÏàͶÄǾÍͶÄÇ£¬ÓëËûûÓÐÈκιØÏµ¡£
ŬÁ¦£¬¸ÄͶ¾ÍÊÇÁË¡£
8Â¥2014-03-21 19:30:56
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ lb1527 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] µ÷¼Á +5 ºÃºÃ¶ÁÊé¡£ 2026-04-01 5/250 2026-04-05 17:54 by liucky
[¿¼ÑÐ] 313Çóµ÷¼Á +5 º£ÈÕº£ÈÕ 2026-04-04 7/350 2026-04-05 13:58 by imissbao
[¿¼ÑÐ] Çóµ÷¼Á +4 wos666 2026-04-03 4/200 2026-04-05 11:48 by arrow8852
[¿¼ÑÐ] 271·ÖÇóµ÷¼ÁѧУ +12 zph158488£¡ 2026-04-02 13/650 2026-04-05 10:13 by lqwchd
[¿¼ÑÐ] 286Çóµ÷¼Á +3 ²Ýľ²»ÑÔ 2026-04-04 3/150 2026-04-04 22:40 by lbsjt
[¿¼ÑÐ] ²ÄÁÏ¿ÆÑ§Ó빤³Ìµ÷¼Á +19 ÉîVËÞÉá°É 2026-03-30 20/1000 2026-04-04 22:13 by hemengdong
[ÂÛÎÄͶ¸å] ÇóÎÄÏ× 5+3 ys879651$ 2026-04-02 3/150 2026-04-04 17:22 by bobvan
[¿¼ÑÐ] 292Çóµ÷¼Á +21 ÊÇåû×ÓÒ²ÊÇÑÐ×Ó 2026-03-30 22/1100 2026-04-03 21:44 by qlm5820
[¿¼ÑÐ] ÎåÒØ´óѧÍÁľ¹¤³ÌÕе÷¼ÁÉú2026 +3 wyutj 2026-03-31 4/200 2026-04-03 18:21 by zengxj_7201
[¿¼ÑÐ] Çóµ÷¼Á +3 usbdndj 2026-04-03 3/150 2026-04-03 14:10 by dxiaoxin
[¿¼ÑÐ] 085801 ×Ü·Ö275 ±¾¿ÆÐÂÄÜÔ´ Çóµ÷¼Á +19 bradoner 2026-04-01 23/1150 2026-04-03 10:07 by linyelide
[¿¼ÑÐ] һ־Ըɽ¶«´óѧ»¯Ñ§Ó뻯¹¤Ñ§Ôº²ÄÁÏÓ뻯¹¤×¨Ë¶£¬360·ÖÇóµ÷¼Á +4 ²»Ô¸Í¸Â¶ÐÕÃûµÄË 2026-04-02 4/200 2026-04-03 09:29 by ÒÅÍüÏûʧµÄž™
[¿¼ÑÐ] Ò»Ö¾Ô¸aÇø211£¬085601-307·ÖÇóµ÷¼Á +13 µ³¼ÎºÀ 2026-03-31 26/1300 2026-04-03 08:33 by 495374996
[¿¼ÑÐ] Ò»Ö¾Ô¸ÉÂÎ÷ʦ·¶´óѧÉúÎïѧ317·Ö +5 1563ÈÕ¡£ 2026-04-02 5/250 2026-04-03 06:58 by ilovexiaobin
[¿¼ÑÐ] ѧ˶»¯Ñ§¹¤³ÌÓë¼¼Êõ£¬Ò»Ö¾Ô¸Öйúº£Ñó´óѧ320+Çóµ÷¼Á +8 ÅûÐÇºÓ 2026-04-02 8/400 2026-04-02 14:12 by oooqiao
[¿¼ÑÐ] 261ÇóBÇøµ÷¼Á +5 Ã÷×С¤ 2026-04-01 7/350 2026-04-02 11:17 by ×Þξξ
[¿¼ÑÐ] ¿¼Ñе÷¼Á +12 Amber00 2026-03-31 12/600 2026-04-02 09:04 by sanrepian
[¿¼ÑÐ] 265Çóµ÷¼Á +11 yelck 2026-04-01 12/600 2026-04-01 19:12 by 549790059
[¿¼ÑÐ] 269Çóµ÷¼Á +4 ÎÒÏë¶ÁÑÐ11 2026-03-31 4/200 2026-03-31 10:04 by cal0306
[¿¼ÑÐ] 297 µØÀíѧ070500 ¸´ÊÔÇóµ÷¼Á +3 СԲȦȦooo 2026-03-30 3/150 2026-03-30 21:05 by ÓàÕðyz
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û